FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Merck Touts Welireg in Kidney Cancer

[ Price : $8.95]

Merck says it will submit to FDA favorable data from its LITESPARK-005 Phase 3 trial evaluating Welireg (belzutifan) for treating ...

FDA Updates Warning on UV Wands

[ Price : $8.95]

FDA updates its list of ultraviolet wand products that may present a potential risk of injury.

GE Mobile Patient Monitor Cleared

[ Price : $8.95]

FDA clears a GE HealthCare 510(k) for its Portrait Mobile wireless and wearable monitoring device.

Medical Device, Drug Recalls Drop in Q2: Sedgwick

[ Price : $8.95]

The Segwick Recall Index shows that both medical device and drug recalls dropped in the second quarter of 2023 from the first quar...

Orphan Status for Biliary Tract Cancer Drug

[ Price : $8.95]

FDA grants Nuvectis Pharmas NXP800 an orphan drug designation for treating biliary tract cancer.

Pentax Endoscope and Video Processor Cleared

[ Price : $8.95]

FDA clears a Pentax Medical 510(k) for its Inspira 4K video processor and the i20c video endoscope.

FDA Oks Ipsens Sohonos for FOP

[ Price : $8.95]

FDA approves Ipsens Sohonos as the first treatment for adults and some pediatric patients with fibrodysplasia ossificans progressi...

Cardiosave Balloon Pump Recall Class 1: FDA

[ Price : $8.95]

FDA says the Datascope/Maquet/Getinge recall of Cardiosave balloon pumps is Class 1.

BlueWind De Novo for Incontinence Device

[ Price : $8.95]

FDA grants BlueWind Medical a de novo marketing authorization request for the Revi System, a tibial neuromodulation therapy for tr...